IDH1 expression was upregulated in several hematologic malignancies, including angioimmunoblastoma, mesenchymal large-cell lymphoma, peripheral T-cell lymphoma, and diffuse large B-cell lymphoma (DLBCL) [57]. Here, IDH1 is linked to diffuse large B-cell lymphoma.